Regional System of Care May Improve Outcomes for TAVR

Share this content:
Regional System of Care May Improve Outcomes for TAVR
Regional System of Care May Improve Outcomes for TAVR

WEDNESDAY, Dec. 30, 2015 (HealthDay News) -- A regional system of care seems beneficial for patients undergoing transcatheter aortic valve replacement (TAVR), according to a study published in the Dec. 28 issue of JACC: Cardiovascular Interventions.

Dion Stub, M.B.B.S., Ph.D., from St. Paul's Hospital in Vancouver, Canada, and colleagues implemented a regional system of care for patients undergoing TAVR in British Columbia, Canada, in a prospective observational cohort study involving 583 patients. Regionalization of care involved a centrally coordinated, funded, and evaluated program, which was led by a medical director and a multidisciplinary advisory team that oversaw planning, access to care, and quality of outcomes. On the basis of consensus provincial indications, heart teams performed risk-stratified case selection for transfemoral TAVR. Referrals for lower volume and more complicated procedures were concentrated at a single site.

The researchers found that transfemoral access and non-transfemoral access was performed in 85.6 and 14.4 percent of cases, respectively. In 7.4 percent of patients, transcatheter valve-in-valve procedures were performed for failed bioprosthetic valves. Overall, 66.2 and 32.4 percent of patients had a balloon-expandable and self-expanding valve inserted, respectively. The all-cause 30-day mortality was 3.5 percent; 3.1 and 1.9 percent of patients experienced all-cause in-hospital mortality and disabling stroke, respectively. The median length of stay was three days; most patients (92.8 percent) were discharged home.

"This experience demonstrates the potential benefits of a regional system of care for TAVR," the authors write.

Several authors disclosed financial ties to the medical device industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »